Clinical data has suggested a link between MECP2 and mTOR, as elevated mTOR phosphorylation and increased P70S6K has been reported in Rett syndrome patient brains (Olson et al., 2018). The gene discussed is MECP2; the disease is atypical Rett syndrome.